OpenAI has met with officials from the U.S. Food and Drug Administration to discuss the agency’s use of AI to speed up drug evaluations, Wired reported on Wednesday. According to the report, OpenAI and the FDA have discussed a project called cderGPT, which seems to be an AI tool for the Center for Drug Evaluation […]
OpenAI and the FDA are reportedly discussing AI for drug evaluations Read More »
As a university student, Dalton Signor was troubled by how many people around him smoked or vaped, including his grandmother and 14-year-old sister. Signor (pictured center) felt that existing smoking cessation medicines, whether patches, gums, or lozenges, are not very effective because they take too long to start working. “They take about 30 minutes to
Although heart disease is the leading cause of death in the United States, a significant portion of people who experience heart attacks are unaware that they have the underlying condition. Cleerly, a cardiovascular imaging startup, hopes to fix this. By analyzing CT scans of the heart, the company’s AI software aims to identify early stage
Cleerly raises $106M from Insight Partners for AI heart health early detection Read More »
